Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma
Hossein Taghizadeh(Comprehensive Cancer Center Vienna), Gerald W. Prager(Comprehensive Cancer Center Vienna)
Cited by 4
Related Papers
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|502
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
|New England Journal of Medicine|2023|415
Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
|Blood|2008|60
Screening for post‐traumatic stress disorders in 1017 cancer patients and correlation with anxiety, depression, and distress
|Psycho-Oncology|2019|52
Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
|Journal of Personalized Medicine|2020|6